[1]
“AWARENESS ABOUT THE RESPONSIBLE USE OF RIVOTRIL: THE ROLE OF THE PHARMACIST IN PATIENT EDUCATION”, REMUNOM, vol. 12, no. 1, Nov. 2024, doi: 10.61164/rmnm.v12i1.3134.